Recent Articles

Prediabetes diet: How to help prevent progression to diabetes

COPD symptoms: How to spot them early

Many older adults get health information from self-defined experts online

Routine cancer screenings for older adults: Mammograms, colonoscopies, PSA tests, and more

How PMOS (once called PCOS) affects women after menopause

Eating more soy and other legumes might ward off high blood pressure

Surgery for a torn meniscus appears to offer no benefit

AI in healthcare: Can a chatbot answer your medical questions?

Increasing daily steps may boost surgical recovery

Poison ivy rash: Symptoms, treatment, and prevention

Guru P. Sonpavde, MD

Contributor

Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.

Posts by Guru P. Sonpavde, MD